leadf
logo-loader
viewAMPEL BioSolutions

AMPEL BioSolutions focused on developing clinical blood test predicts the correct drug for a patient

AMPEL BioSolutions COO Dr Amrie Grammer chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Charlottesville, Virginia-based company can identify drugs for treating lupus patients. According to its website, the company's system can be applied to any disease.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Luminex Resources CEO says stay tuned for drill results out of its Condor...

Luminex Resources Corp. (TSXV: LR) (OTCQX: LUMIF) CEO Marshall Koval tells Proactive the Vancouver-based mining company is making progress on its Condor Gold-Copper Project in Zamora-Chinchipe Province, southeast Ecuador. Koval says the group has advanced metallurgy at the site, continuing to...

2 days, 4 hours ago

2 min read